Showing results (261-270 of 295) with videos related to
Sort By:
Pageof 30
Cancer Medicine|May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinomaEmerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic ImpairmentNima Nabavizadeh, Joseph G Waller, Robert Fain, et al.JAMA Network Open|May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical TrialsMarcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.American Journal of Clinical Oncology|September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal CancerSuzanne Russo, A William Blackstock, Joseph M Herman, et al.Journal of Gastrointestinal Oncology|July 20, 2012
Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignanciesKilian Salerno May, Gary Y Yang, Nikhil I Khushalani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial MisinterpretationTimothy A Lin, Zachary R McCaw, Alex Koong, et al.Pageof 30